IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · Real-Time Price · USD
31.85
-1.75 (-5.21%)
Apr 21, 2026, 9:42 AM EDT - Market open
IDEAYA Biosciences Analyst Ratings
Total Analysts
16
Consensus Rating
Strong Buy
Price Target
$52.86
Upside
+65.97%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Hold Maintains $31 → $35 | Hold | Maintains | $31 → $35 | +9.89% | Apr 14, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $44 → $48 | Buy | Maintains | $44 → $48 | +50.71% | Apr 14, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $49 → $53 | Buy | Maintains | $49 → $53 | +66.41% | Apr 14, 2026 |
| Wedbush | Wedbush | Buy Maintains $52 → $58 | Buy | Maintains | $52 → $58 | +82.10% | Apr 14, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $50 → $54 | Strong Buy | Maintains | $50 → $54 | +69.54% | Apr 14, 2026 |
| Wedbush | Wedbush | Buy Reiterates $52 | Buy | Reiterates | $52 | +63.27% | Mar 31, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $64 → $65 | Strong Buy | Maintains | $64 → $65 | +104.08% | Feb 19, 2026 |
| RBC Capital | RBC Capital | Buy Reiterates $49 | Buy | Reiterates | $49 | +53.85% | Feb 18, 2026 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +56.99% | Feb 18, 2026 |
| Wedbush | Wedbush | Buy Maintains $49 → $52 | Buy | Maintains | $49 → $52 | +63.27% | Feb 18, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $41 → $45 | Buy | Maintains | $41 → $45 | +41.29% | Jan 21, 2026 |
| UBS | UBS | Strong Buy Initiates $50 | Strong Buy | Initiates | $50 | +56.99% | Jan 7, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $59 → $60 | Strong Buy | Maintains | $59 → $60 | +88.38% | Jan 6, 2026 |
| Truist Securities | Truist Securities | Strong Buy Initiates $59 | Strong Buy | Initiates | $59 | +85.24% | Nov 24, 2025 |
| Mizuho | Mizuho | Buy Maintains $44 → $46 | Buy | Maintains | $44 → $46 | +44.43% | Nov 11, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $74 → $79 | Buy | Maintains | $74 → $79 | +148.04% | Oct 23, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.